Organovo Presents FXR314 3D Human Tissue Model Findings
Author: Benzinga Newsdesk | January 25, 2024 09:06am
The presentation highlights preclinical data characterizing the activity of FXR314 in 3D models of human Crohn's disease and ulcerative colitis. FXR314 broadly improved measures of epithelial barrier function in a subset of donors, and fibrotic markers in all Crohn's disease donors. In ulcerative colitis, FXR314 improved epithelial barrier function and fibrotic activity in all donors.
Posted In: ONVO